OBJECTIVE: We sought to evaluate the interaction between repeated-course antenatal corticosteroids and inflammation gene polymorphisms with neurodevelopmental outcomes at age 2 years. STUDY DESIGN: We conducted nested case-control analysis of a randomized controlled trial of single- vs repeated-course antenatal corticosteroids. Cases had mental and/or psychomotor delay at age 2 years. Controls had normal neurodevelopment. Previous analyses of 125 cases and 147 controls identified 4 inflammation gene polymorphisms associated with neurodevelopmental delay at age 2 years. RESULTS: The interaction between repeated-course corticosteroids and the interleukin (IL)-6 -174 genotype with neurodevelopmental delay was significant (P = .046). The IL-6 -174 GG genotype was associated with neurodevelopmental delay at age 2 years in the single-course corticosteroid group (odds ratio, 6.47; 95% confidence interval, 1.86-22.50). Exposure to repeated-course antenatal corticosteroids abrogated this genotype effect (odds ratio, 1.30; 95% confidence interval, 0.48-3.54). Results were unchanged after controlling for potential confounders. CONCLUSION: Repeated-course antenatal steroids may reduce the increased risk of neurodevelopmental delay at age 2 years associated with IL-6 -174 GG genotype.
RCT Entities:
OBJECTIVE: We sought to evaluate the interaction between repeated-course antenatal corticosteroids and inflammation gene polymorphisms with neurodevelopmental outcomes at age 2 years. STUDY DESIGN: We conducted nested case-control analysis of a randomized controlled trial of single- vs repeated-course antenatal corticosteroids. Cases had mental and/or psychomotor delay at age 2 years. Controls had normal neurodevelopment. Previous analyses of 125 cases and 147 controls identified 4 inflammation gene polymorphisms associated with neurodevelopmental delay at age 2 years. RESULTS: The interaction between repeated-course corticosteroids and the interleukin (IL)-6 -174 genotype with neurodevelopmental delay was significant (P = .046). The IL-6 -174 GG genotype was associated with neurodevelopmental delay at age 2 years in the single-course corticosteroid group (odds ratio, 6.47; 95% confidence interval, 1.86-22.50). Exposure to repeated-course antenatal corticosteroids abrogated this genotype effect (odds ratio, 1.30; 95% confidence interval, 0.48-3.54). Results were unchanged after controlling for potential confounders. CONCLUSION: Repeated-course antenatal steroids may reduce the increased risk of neurodevelopmental delay at age 2 years associated with IL-6 -174 GG genotype.
Authors: Hongmin Chen; Leon M Wilkins; Nazneen Aziz; Christopher Cannings; David H Wyllie; Colin Bingle; John Rogus; James D Beck; Steven Offenbacher; Michael J Cork; Maryam Rafie-Kolpin; Chung-Ming Hsieh; Kenneth S Kornman; Gordon W Duff Journal: Hum Mol Genet Date: 2006-01-06 Impact factor: 6.150
Authors: David Harding; David Brull; Steve E Humphries; Andrew Whitelaw; Hugh Montgomery; Neil Marlow Journal: Pediatr Res Date: 2005-07 Impact factor: 3.756
Authors: Ch Härtel; D Finas; P Ahrens; E Kattner; Th Schaible; D Müller; H Segerer; K Albrecht; J Möller; K Diedrich; W Göpel Journal: Mol Hum Reprod Date: 2004-10-29 Impact factor: 4.025
Authors: Hyagriv N Simhan; Marijane A Krohn; James M Roberts; Adriana Zeevi; Steve N Caritis Journal: Am J Obstet Gynecol Date: 2003-10 Impact factor: 8.661
Authors: Michael W Varner; Maged M Costantine; Kathleen A Jablonski; Dwight J Rouse; Brian M Mercer; Kenneth J Leveno; Uma M Reddy; Catalin Buhimschi; Ronald J Wapner; Yoram Sorokin; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Mary J O'sullivan; Alan M Peaceman; Donald J Dudley; Steve N Caritis Journal: Am J Perinatol Date: 2019-02-07 Impact factor: 1.862